$59,273,750
to TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE
AWARD OF THE BASE TO UPENN FOR CEIRR CONTRACT 75N93021C00015. THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR)
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funding increment for UPenn's ongoing influenza research program (initiated 2021), supporting NIH's Centers of Excellence for Influenza Research and Response.
Strengthens U.S. pandemic preparedness capacity through academic research on influenza vaccines and response, critical for future outbreak mitigation.
Sustains demand for research reagents, lab equipment, and vaccine development materials through academic research infrastructure.
Maintains U.S. leadership in vaccine research and pandemic preparedness against competing global capabilities in China and Russia.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-07. Cost: $0.018299.
- 2026-04-20ABRAMSON CANCER CENTER OF THE U OF P CORE SUPPORT GRANT$163.2M
- 2026-04-22ALZHEIMER'S DISEASE GENETICS CONSORTIUM$60.4M
- —ARCHES: AUTONOMOUS RESILIENT COGNITIVE HETEROGENEOUS SWARMS$48.5M
- —RESEARCH IN HIGH ENERGY PHYSICS AT THE UNIVERSITY OF PENNSYLVANIA$41.6M
- —PENN PREVENTION CLINICAL TRIALS UNIT$33.0M
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75N93021C00015_7529_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.